Literature DB >> 21159923

Antibody response to polyhistidine-tagged peptide and protein antigens attached to liposomes via lipid-linked nitrilotriacetic acid in mice.

Douglas S Watson1, Virginia M Platt, Limin Cao, Vincent J Venditto, Francis C Szoka.   

Abstract

Particulate delivery systems enhance antibody responses to subunit antigens. However, covalent attachment of protein antigens can disrupt protein structure and mask critical epitopes, altering the antibody response to the antigen. In this report, we evaluate noncovalent metal chelation via nitrilotriacetic acid (NTA) as a nondestructive method to attach peptide and protein antigens to liposomes. Two model antigens, ovalbumin (OVA) and a peptide derived from the membrane-proximal region of HIV-1 gp41 (N-MPR), were polyhistidinylated and attached to liposomes via monovalent NTA (mono-NTA; K(D) [equilibrium dissociation constant], ∼10 μM), trivalent NTA (tris-NTA; K(D), ∼1 nM), or a covalent linkage. Attachment of N-MPR, but not OVA, to liposomes via an NTA lipid elicited stronger antibody responses in BALB/c mice than a formulation in which unassociated antigen was simply admixed with control liposomes lacking NTA. However, the tris-NTA linkage did not increase antibody responses to either N-MPR or OVA compared to the level for the mono-NTA linkage, despite the greater liposomal association of the antigen. For both antigens, covalently attaching them to a lipid elicited significantly stronger antibody responses than NTA-anchored antigens (OVA titer, 3.4 × 10(6) versus 1.4 × 10(6) to 1.6 × 10(6) [P < 0.001]; N-MPR titer, 4.4 × 10(4) versus 5.5 × 10(2) to 7.6 × 10(2) [P < 0.003]). The data indicate that NTA linkages may increase antibody titers to weak antigens such as N-MPR, but NTA-mediated attachment remains inferior to covalent conjugation. Moreover, enhancements in antigen-liposome affinity do not result in increased antibody titers. Thus, additional improvements of NTA-mediated conjugation technology are necessary to achieve an effective, nondestructive method for increasing the humoral response to antigens in particulate vaccines.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21159923      PMCID: PMC3067350          DOI: 10.1128/CVI.00425-10

Source DB:  PubMed          Journal:  Clin Vaccine Immunol        ISSN: 1556-679X


  48 in total

Review 1.  Liposomes as carriers of peptide antigens: induction of antibodies and cytotoxic T lymphocytes to conjugated and unconjugated peptides.

Authors:  C R Alving; V Koulchin; G M Glenn; M Rao
Journal:  Immunol Rev       Date:  1995-06       Impact factor: 12.988

2.  Enhanced responses to a DNA vaccine encoding a fusion antigen that is directed to sites of immune induction.

Authors:  J S Boyle; J L Brady; A M Lew
Journal:  Nature       Date:  1998-03-26       Impact factor: 49.962

3.  Controlled release microparticles as a single dose hepatitis B vaccine: evaluation of immunogenicity in mice.

Authors:  M Singh; X M Li; J P McGee; T Zamb; W Koff; C Y Wang; D T O'Hagan
Journal:  Vaccine       Date:  1997-04       Impact factor: 3.641

4.  Antigen presentation by B cells and macrophages of cytochrome c and its antigenic fragment when conjugated to the surface of liposomes.

Authors:  P R Dal Monte; F C Szoka
Journal:  Vaccine       Date:  1989-10       Impact factor: 3.641

5.  Monophosphoryl lipid A enhances specific CTL induction by a soluble protein antigen entrapped in liposomes.

Authors:  F Zhou; L Huang
Journal:  Vaccine       Date:  1993       Impact factor: 3.641

6.  Cationic lipid DC-Chol induces an improved and balanced immunity able to overcome the unresponsiveness to the hepatitis B vaccine.

Authors:  F Brunel; A Darbouret; J Ronco
Journal:  Vaccine       Date:  1999-04-23       Impact factor: 3.641

7.  The release and detection of endotoxin from liposomes.

Authors:  P Harmon; D Cabral-Lilly; R A Reed; F P Maurio; J C Franklin; A Janoff
Journal:  Anal Biochem       Date:  1997-08-01       Impact factor: 3.365

Review 8.  Adjuvants for human vaccines--current status, problems and future prospects.

Authors:  R K Gupta; G R Siber
Journal:  Vaccine       Date:  1995-10       Impact factor: 3.641

9.  How to measure and predict the molar absorption coefficient of a protein.

Authors:  C N Pace; F Vajdos; L Fee; G Grimsley; T Gray
Journal:  Protein Sci       Date:  1995-11       Impact factor: 6.725

10.  Molecular organization of histidine-tagged biomolecules at self-assembled lipid interfaces using a novel class of chelator lipids.

Authors:  C Dietrich; L Schmitt; R Tampé
Journal:  Proc Natl Acad Sci U S A       Date:  1995-09-26       Impact factor: 11.205

View more
  26 in total

Review 1.  Liposomes as vaccine delivery systems: a review of the recent advances.

Authors:  Reto A Schwendener
Journal:  Ther Adv Vaccines       Date:  2014-11

Review 2.  Design considerations for liposomal vaccines: influence of formulation parameters on antibody and cell-mediated immune responses to liposome associated antigens.

Authors:  Douglas S Watson; Aaron N Endsley; Leaf Huang
Journal:  Vaccine       Date:  2012-02-02       Impact factor: 3.641

3.  Lipid nanocapsule as vaccine carriers for his-tagged proteins: evaluation of antigen-specific immune responses to HIV I His-Gag p41 and systemic inflammatory responses.

Authors:  Saurabh Wadhwa; Anekant Jain; Jerold G Woodward; Russell J Mumper
Journal:  Eur J Pharm Biopharm       Date:  2011-10-31       Impact factor: 5.571

Review 4.  A review of nanotechnological approaches for the prophylaxis of HIV/AIDS.

Authors:  Abhijit A Date; Christopher J Destache
Journal:  Biomaterials       Date:  2013-05-28       Impact factor: 12.479

Review 5.  Key roles of adjuvants in modern vaccines.

Authors:  Steven G Reed; Mark T Orr; Christopher B Fox
Journal:  Nat Med       Date:  2013-12-05       Impact factor: 53.440

6.  Vaccine nanoparticles displaying recombinant Ebola virus glycoprotein for induction of potent antibody and polyfunctional T cell responses.

Authors:  Joseph D Bazzill; Sabrina M Stronsky; Laura C Kalinyak; Lukasz J Ochyl; Jesse T Steffens; Sean A van Tongeren; Christopher L Cooper; James J Moon
Journal:  Nanomedicine       Date:  2018-11-22       Impact factor: 5.307

7.  Kinetics of Histidine-Tagged Protein Association to Nickel-Decorated Liposome Surfaces.

Authors:  Gokul Raghunath; R Brian Dyer
Journal:  Langmuir       Date:  2019-09-09       Impact factor: 3.882

8.  Rational design of membrane proximal external region lipopeptides containing chemical modifications for HIV-1 vaccination.

Authors:  Vincent J Venditto; Douglas S Watson; Michael Motion; David Montefiori; Francis C Szoka
Journal:  Clin Vaccine Immunol       Date:  2012-10-31

9.  Working together: interactions between vaccine antigens and adjuvants.

Authors:  Christopher B Fox; Ryan M Kramer; Lucien Barnes V; Quinton M Dowling; Thomas S Vedvick
Journal:  Ther Adv Vaccines       Date:  2013-05

Review 10.  Designer lipids for drug delivery: from heads to tails.

Authors:  Aditya G Kohli; Paul H Kierstead; Vincent J Venditto; Colin L Walsh; Francis C Szoka
Journal:  J Control Release       Date:  2014-05-06       Impact factor: 9.776

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.